METOJECT Trademark

Trademark Overview

On Thursday, August 2, 2007, a trademark application was filed for METOJECT with the United States Patent and Trademark Office. The USPTO has given the METOJECT trademark a serial number of 79043799. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, September 27, 2022. This trademark is owned by medac Gesellschaft für klinische; Spezialpräparate mbH. The METOJECT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating cancer and autoimmune diseases
metoject

General Information

Serial Number79043799
Word MarkMETOJECT
Filing DateThursday, August 2, 2007
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, September 27, 2022
Registration Number3468265
Registration DateTuesday, July 15, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating cancer and autoimmune diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 20, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Namemedac Gesellschaft für klinische Spezialpräparate mbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWedel 22880
DE
Party Namemedac Gesellschaft für klinische; Spezialpräparate mbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE
Party Namemedac Gesellschaft für klinische; Spezialpräparate mbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events

Event DateEvent Description
Tuesday, April 18, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Tuesday, April 18, 2023DEATH OF INTERNATIONAL REGISTRATION
Thursday, February 16, 2017NEW REPRESENTATIVE AT IB RECEIVED
Monday, January 4, 2016TOTAL INVALIDATION PROCESSED BY THE IB
Friday, December 11, 2015GENERIC MADRID TRANSACTION SENT TO IB
Friday, December 11, 2015GENERIC MADRID TRANSACTION CREATED
Tuesday, October 20, 2015TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 20, 2015CANCELLED SECTION 71
Saturday, December 29, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, October 23, 2012INTERNATIONAL REGISTRATION RENEWED
Monday, November 3, 2008FINAL DISPOSITION NOTICE SENT TO IB
Monday, November 3, 2008FINAL DISPOSITION PROCESSED
Thursday, October 16, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 15, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, April 29, 2008PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2008NOTICE OF PUBLICATION
Tuesday, March 25, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 25, 2008ASSIGNED TO LIE
Tuesday, March 11, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 3, 2008ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 3, 2008TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 3, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 3, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 3, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 6, 2007REFUSAL PROCESSED BY IB
Thursday, November 15, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 15, 2007REFUSAL PROCESSED BY MPU
Thursday, November 15, 2007NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 14, 2007NON-FINAL ACTION WRITTEN
Thursday, November 8, 2007ASSIGNED TO EXAMINER
Friday, October 12, 2007NEW APPLICATION ENTERED
Friday, October 12, 2007SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

metoject autoimmune diseases cancer treating preparations pharmaceutical